With a view to strengthen its ties with
the Middle Eastern regions, the Pharmaceutical Export Promotion Council
(Pharmexcil) organized a high level business meet with the delegates from the
Middle Eastern countries in Mumbai recently. This is the first time that
Pharmexcil had organized such an interactive session with the Middle Eastern
countries, to promote pharma exports to these regions.
A senior official of Pharmexcil informed that the Council had organized this meet strategically, keeping in mind to exploit business opportunities arising out of the CPhI event in Mumbai from November 30 to December 2.
About 50 delegates from United Arab Emirates (UAE), Egypt, Oman, Qatar, Syria, Iran, Iraq and Jordan had participated in this buyer-seller meet, where they met and interacted with 150 Indian manufacturers from the small and medium scale pharma industries from across the country.
The representatives from these countries had detailed discussions with their Indian counterparts during the two-day meet, where they had one-to-one interaction with the other to explore business opportunities in future. In fact, the foreign delegates acknowledged that they were very impressed by the capabilities of the Indian manufacturers to supply quality medicines at affordable rates and stressed on strengthening their business ties.
As per the data provided by Pharmexcil, India has 30 per cent of market share in the Asian market out of which 10 per cent comes from Middle Eastern countries alone. Dr Appaji added that since Middle Eastern countries have a lot of export potential it should be tapped appropriately by the Indian companies to expand their business in these regions.
A senior official of Pharmexcil informed that the Council had organized this meet strategically, keeping in mind to exploit business opportunities arising out of the CPhI event in Mumbai from November 30 to December 2.
About 50 delegates from United Arab Emirates (UAE), Egypt, Oman, Qatar, Syria, Iran, Iraq and Jordan had participated in this buyer-seller meet, where they met and interacted with 150 Indian manufacturers from the small and medium scale pharma industries from across the country.
The representatives from these countries had detailed discussions with their Indian counterparts during the two-day meet, where they had one-to-one interaction with the other to explore business opportunities in future. In fact, the foreign delegates acknowledged that they were very impressed by the capabilities of the Indian manufacturers to supply quality medicines at affordable rates and stressed on strengthening their business ties.
As per the data provided by Pharmexcil, India has 30 per cent of market share in the Asian market out of which 10 per cent comes from Middle Eastern countries alone. Dr Appaji added that since Middle Eastern countries have a lot of export potential it should be tapped appropriately by the Indian companies to expand their business in these regions.
No comments:
Post a Comment